DAVID HUI to Phosphodiesterase 4 Inhibitors
This is a "connection" page, showing publications DAVID HUI has written about Phosphodiesterase 4 Inhibitors.
Connection Strength
0.259
-
Adherence to a COPD treatment guideline among patients in Hong Kong. Int J Chron Obstruct Pulmon Dis. 2017; 12:3371-3379.
Score: 0.156
-
Roflumilast in Asian patients with COPD: A randomized placebo-controlled trial. Respirology. 2011 Nov; 16(8):1249-57.
Score: 0.103